Shares of Getinge (OTCMKTS:GNGBY – Get Free Report) hit a new 52-week high on Wednesday . The stock traded as high as $25.22 and last traded at $25.16, with a volume of 4601 shares changing hands. The stock had previously closed at $25.05.
Wall Street Analysts Forecast Growth
Separately, Zacks Research upgraded Getinge from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, July 21st. One research analyst has rated the stock with a Strong Buy rating and one has given a Buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Strong Buy”.
View Our Latest Analysis on Getinge
Getinge Stock Performance
Getinge (OTCMKTS:GNGBY – Get Free Report) last issued its quarterly earnings data on Friday, July 17th. The company reported $0.38 EPS for the quarter. The firm had revenue of $894.87 million during the quarter. Getinge had a net margin of 7.81% and a return on equity of 11.12%. As a group, sell-side analysts expect that Getinge will post 1.38 earnings per share for the current year.
Getinge Company Profile
Getinge AB is a global medical technology company that develops, manufactures and markets products and systems for hospitals and life sciences institutions. The company’s offerings focus on critical care, surgical workflows and infection control, aiming to improve clinical outcomes and operational efficiency. Getinge’s solutions support a range of applications from intensive care and cardiovascular treatments to sterile reprocessing of surgical instruments.
The company’s product portfolio includes sterilization and disinfection equipment, surgical tables and lights, ventilation systems, heart-lung machines and extracorporeal membrane oxygenation (ECMO) devices.
Recommended Stories
- Five stocks we like better than Getinge
- System Upgrade: First Internet Bancorp Options Surge
- AI Security Breaches Raise New Risks for Microsoft and Amazon’s Agent Push
- The AI Chip Blockade Is Creating a Shadow Market
- Grab Holdings Stock Forms Bottom After Strong Beat-and-Raise Quarter
Receive News & Ratings for Getinge Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Getinge and related companies with MarketBeat.com's FREE daily email newsletter.
